Target intelligence / Profile preview

Gastrointestinal absorption of glucose and cholesterol

Molecular classification
Transporter
01

Overview

The term "gastrointestinal absorption of glucose and cholesterol" refers collectively to the complex set of cellular processes by which dietary sugars and sterols are taken up from the intestinal lumen into enterocytes, then transported into circulation. Glucose is primarily absorbed via sodium-dependent co-transporter SGLT1 at the apical membrane followed by facilitated diffusion through GLUT2 at the basolateral membrane into portal blood. Cholesterol is absorbed mainly via Niemann-Pick C-like protein 1 (NPC1L1) at the brush border membrane; other proteins like SR-BI and CD36 also contribute. These pathways are regulated by dietary composition, hormonal signals, intracellular signaling cascades including protein kinase C activation, transcription factors such as LXR-alpha/beta and PPARs, among others[3][7]. Alterations in these absorptive mechanisms play key roles in metabolic diseases including diabetes mellitus type 2—where high luminal glucose enhances both its own uptake and that of cholesterol—and cardiovascular disease due to increased postprandial lipemia associated with excessive lipid/cholesterol intake/absorption[3][7]. Several drugs act on these pathways either directly inhibiting specific transporters or indirectly modulating their activity/expression. Because this entry does not correspond to a unique molecular entity but rather an aggregate function involving multiple well-defined targets—each with their own canonical names—it should be considered non-canonical for structured drug-target databases.

Other names
Intestinal glucose absorptionIntestinal cholesterol absorptionGlucose uptake (intestinal)Cholesterol uptake (intestinal)
02

Mechanism of action

For drugs targeting these pathways: SGLT inhibitors block sodium-glucose cotransport in the intestine/kidney. Ezetimibe inhibits NPC1L1-mediated intestinal cholesterol uptake. Polyphenols may inhibit facilitated diffusion or active transport mechanisms for both nutrients indirectly by modulating transporter expression/activity[5].

03

Biological functions

Nutrient absorptionEnergy homeostasisLipid metabolism
04

Disease associations

Type 2 diabetes mellitusCardiovascular diseaseHypercholesterolemiaMetabolic syndrome
05

Safety considerations

Inhibition may cause gastrointestinal side effects such as diarrhea or malabsorption.Over-inhibition can lead to hypoglycemia with SGLT inhibitors.Long-term alteration in lipid/glucose handling may affect cardiovascular risk profiles.
06

Interacting drugs

canagliflozin

3 more in the full profile.

07

Biomarkers

Postprandial blood glucose levelsSerum LDL-cholesterol levelsExpression levels of individual transporters like SGLT1 or NPC1L1

Beyond the preview

Go deeper on Gastrointestinal absorption of glucose and cholesterol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal absorption of glucose and cholesterol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call